Quasar Medical takes minority stake in Swedish catheter startup CathPrint
What's the deal? QuasarDealroom has a profile for this one. Try Dealroom → Medical, a contract developer and manufacturer of minimally invasive devices, has made a minority investment in CathPrintDealroom has a profile for this one. Try Dealroom →, a Swedish medtech company that builds catheter electronics on flexible printed circuits. Announced on November 10, the deal also includes a strategic collaboration agreement to explore catheter design and development services. The stake size was not disclosed.
What's the endgame? CathPrint's e-shaft platform integrates a flat, full-length flexible circuit onto a catheter shaft, replacing individually routed wires. It supports higher electrode density, more design freedom, and automated assembly.
Why it matters? In a conventional catheter, each electrode gets its own conductor threaded down the shaft by hand, so assembly time grows with every electrode added. CathPrint says its platform can cut active operator time for a 10-electrode catheter from roughly 1.5–2 hours to 10 minutes, and in one customer case estimated electrode assembly costs could fall by about 67%. Those are the company's own figures.
Why now? The investment follows Quasar's purchase of the Medres Nitinol Design and Development Center in California this summer, part of a push to broaden its catheter-development capabilities. CathPrint, which remains independent, has run development programs with catheter OEMs and CDMOs since 2022.
The platform targets electrophysiology mapping, pulsed field ablation, balloon and basket catheters, and advanced sensing and navigation. Through the partnership, the two firms aim to introduce CathPrint's technology to a broader international customer base, drawing on Quasar's global presence.
What could go wrong? Both companies describe the collaboration as exploratory, and neither has named programs or timelines. Conductors embedded in a reflowed shaft wall face the same bending and torque loads as the shaft itself, meaning flex-circuit designs likely need qualifying as new constructions rather than drop-in swaps.
What they said? "As catheter designs become increasingly complex, innovations in flexible electronics may simplify manufacturing and enable more advanced functionality," said Quasar chief executive officer Alex Wallstein. CathPrint CEO Jacob Ahlsson called the investment "an important step towards commercial scale."
The signal: For Quasar, the value is strategic access to a potentially useful manufacturing technology and a wider customer base, rather than a disclosed large financing or near-term product launch. Whether the collaboration reaches production will become clearer as joint design projects take shape.
Read more: mpo-mag.com
Image credit: Generated with Gemini